GGrantIndex
Sort

16,300 grants matching fatty liver disease

Nonalcoholic fatty liver disease, associated lipidomic changes, and preeclampsia risk

$190,666
Tatyana Kushner · Icahn School Of Medicine At Mount Sinai · K23 · FY2023 · HL

Regulation of mitochondrial function in T cells

$190,625
Mercedes R. Rincon · University Of Vermont & St Agric College · R21 · FY2015 · AI

NEUROPROTECTIVE EFFECTS OF KETONE BODY OXIDATION IN CEREBRAL ISCHEMIA

$190,625
Kwee Liu Lin Thio · Washington University · R21 · FY2015 · NS

REAL TIME ULTRASOUND ENTROPY-BASED QUANTIFICATION OF FIBROFATTY LIVER DISEASE

$190,625
John E. McCarthy · Washington University · R21 · FY2016 · EB

Mitochondrial dynamics in alcohol-induced tissue injury

$190,593
David C Chan · California Institute Of Technology · R21 · FY2008 · AA

Project 3: Environmental PPARγ Pathway Activators: Multifaceted Metabolic Disruptors Impacting Adipose and Bone Homeostatsis

$190,245
Jennifer J Schlezinger · Boston University Medical Campus · P42 · FY2017 · ES

The H-scan approach to classifying ultrasound echoes

$190,145
Kevin J Parker · University Of Rochester · R21 · FY2018 · EB

Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASH

$190,134
Monika Sarkar · University Of California, San Francisco · K23 · FY2021 · DK

Lipocalin 2 in inflammation and metabolic control

$190,000
Xiaoli Chen · University Of Minnesota · R56 · FY2013 · DK

Alcohol Intake and Hepatic Fat Metabolism

$190,000
Li Shin Huang · Columbia University Health Sciences · R21 · FY2012 · AA

THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS

$190,000
Paul T Kotzbauer · Washington University · R21 · FY2012 · NS

Administrative Core

$189,986
Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2023 · CA

Elucidating the Roles of Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease among Asian American Patients with Chronic Hepatitis B

$189,986
Lin Zhu · Temple Univ Of The Commonwealth · U54 · FY2023 · CA

Clinical utility of leptin therapy in syndromic forms of insulin resistance.

$189,984
Phillip Gorden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

The Impact of Stress and Resilience on Obesity-Related Metabolic Complications in Adolescents

$189,929
Idia Binitie Thurston · University Of Memphis · R21 · FY2018 · DK

Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks

$189,920
Christina Chan · Michigan State University · R01 · FY2009 · GM

The pathological role of nicotinamide N-methyltransferase in alcoholic liver disease

$189,881
Zhenyuan Song · University Of Illinois At Chicago · R21 · FY2017 · AA

Testing a Unique HDL Mimetic Peptide to Reverse ApoE4 Lipidation Deficiency and Alzheimer's Neuropathology

$189,846
Ling Li · University Of Minnesota · R21 · FY2017 · AG

Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs

$189,810
Sanjay Srivastava · University Of Louisville · P42 · FY2017 · ES

The role of FIT2 in VLDL assembly, hepatic triglyceride homeostasis, and lipoprotein atherogenicity

$189,780
Edward A Fisher · New York University School Of Medicine · R01 · FY2023 · HL

A molecular mechanism whereby metformin protects against liver cancer

$189,664
Hua Xiao · Michigan State University · R21 · FY2014 · CA

Project 3 - Molecular mechanisms of acute ethanol behaviors in C. elegans

$189,546
Jill C Bettinger · Virginia Commonwealth University · P50 · FY2021 · AA

Microbial provision of essential amino acids: protein conservation in hibernation

$189,413
Khrystyne Duddleston · University Of Alaska Fairbanks · P20 · FY2020 · GM

Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV

$189,375
Morris Schambelan · University Of California, San Francisco · R21 · FY2006 · AT

Circadian Expression of Procolipase in the Liver: A Metabolic Signal

$189,375
Mark E. Lowe · University Of Pittsburgh At Pittsburgh · R21 · FY2009 · DK